Saudi Biotech Fund IB Ventures Launches With $50 Million Raise

Saudi Arabia has launched IB Ventures, a new investment platform dedicated to the biotechnology industry, with an initial funding round of $50 million. The fund is established to support the growth of local biotech firms by financing development, expanding marketing capabilities, and scaling emerging projects. It forms part of the broader strategy to diversify the kingdom’s economy and strengthen its life-sciences ecosystem. IB Ventures will target companies operating in areas such as therapeutics, diagnostics, digital biology, and manufacturing. The platform will also offer exit opportunities and help link Saudi-based firms with global partners and markets. Industry analysts say the fund reflects the increasing prioritisation of biotechnology within Saudi Arabia’s innovation agenda, aligning with international trends and the kingdom’s goal to transition toward more advanced sectors.